Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry.
Pedersen MB, Hamilton-Dutoit SJ, Bendix K, Møller MB, Nørgaard P, Johansen P, Ralfkiaer E, Brown Pde N, Hansen PB, Jensen BA, Madsen J, Schöllkopf C, d'Amore F. Pedersen MB, et al. Among authors: norgaard p. Hematol Oncol. 2015 Dec;33(4):120-8. doi: 10.1002/hon.2153. Epub 2014 Jul 23. Hematol Oncol. 2015. PMID: 25052551
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
Pedersen MB, Hamilton-Dutoit SJ, Bendix K, Ketterling RP, Bedroske PP, Luoma IM, Sattler CA, Boddicker RL, Bennani NN, Nørgaard P, Møller MB, Steiniche T, d'Amore F, Feldman AL. Pedersen MB, et al. Among authors: norgaard p. Blood. 2017 Jul 27;130(4):554-557. doi: 10.1182/blood-2016-12-755496. Epub 2017 May 18. Blood. 2017. PMID: 28522440 Free PMC article. No abstract available.
Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
Ludvigsen M, Bjerregård Pedersen M, Lystlund Lauridsen K, Svenstrup Poulsen T, Hamilton-Dutoit SJ, Besenbacher S, Bendix K, Møller MB, Nørgaard P, d'Amore F, Honoré B. Ludvigsen M, et al. Among authors: norgaard p. Blood Adv. 2018 Oct 9;2(19):2533-2542. doi: 10.1182/bloodadvances.2018019893. Blood Adv. 2018. PMID: 30291111 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 31780632
Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Holst JM, Plesner TL, Pedersen MB, Frederiksen H, Møller MB, Clausen MR, Hansen MC, Hamilton-Dutoit SJ, Nørgaard P, Johansen P, Ramm Eberlein T, Mortensen BK, Mathiasen G, Øvlisen A, Wang R, Wang C, Zhang W, Beier Ommen H, Stentoft J, Ludvigsen M, Tam W, Chan WC, Inghirami G, d'Amore F. Holst JM, et al. Among authors: norgaard p. Haematologica. 2020 Oct 1;105(10):2432-2439. doi: 10.3324/haematol.2019.225839. Haematologica. 2020. PMID: 33054083 Free PMC article.
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
Luchtel RA, Dasari S, Oishi N, Pedersen MB, Hu G, Rech KL, Ketterling RP, Sidhu J, Wang X, Katoh R, Dogan A, Kip NS, Cunningham JM, Sun Z, Baheti S, Porcher JC, Said JW, Jiang L, Hamilton-Dutoit SJ, Møller MB, Nørgaard P, Bennani NN, Chng WJ, Huang G, Link BK, Facchetti F, Cerhan JR, d'Amore F, Ansell SM, Feldman AL. Luchtel RA, et al. Among authors: norgaard p. Blood. 2018 Sep 27;132(13):1386-1398. doi: 10.1182/blood-2018-03-838524. Epub 2018 Aug 9. Blood. 2018. PMID: 30093402 Free PMC article.
Proteomic Profiling Differentiates Lymphoma Patients with and without Concurrent Myeloproliferative Neoplasia.
Holst JM, Enemark MB, Pedersen MB, Lauridsen KL, Hybel TE, Clausen MR, Frederiksen H, Møller MB, Nørgaard P, Plesner TL, Hamilton-Dutoit SJ, d'Amore F, Honoré B, Ludvigsen M. Holst JM, et al. Among authors: norgaard p. Cancers (Basel). 2021 Nov 3;13(21):5526. doi: 10.3390/cancers13215526. Cancers (Basel). 2021. PMID: 34771688 Free PMC article.
125 results